Finance ForgeBETA
Crear cuenta gratis
1)Empresas2)Rankings3)Iniciar sesión
Finance Forge Terminal v1.51.3
PrivacidadTérminosCookiesAviso Legal
● Connected
AEMD US Equity
AETHLON MEDICAL INC
5.58USD▼ 4.78%
Healthcare
Medical Devices
96)Comparar97)Tesis →
Market Cap
$9M
Shares Outstanding
2M
Net Income (TTM)
−$7M
— Annual —FY2026
ROE
-146.4%
ROCE
-149.3%
Current Ratio
3.85
FCF / Share
-4.37
Book Value / Share
3.05
AEMD US Equity
5.58USD▼ 4.78%
Tesis →

AETHLON MEDICAL INC (AEMD): análisis fundamental y valoración

AETHLON MEDICAL INC cotiza a 5.58 USD y tiene una capitalización bursátil de $9M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud

Price History
Loading...
Perfil
BolsaNasdaqPaísUnited StatesEmpleados9Beta1.21Web↗ www.aethlonmedical.com

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other diseas…

Múltiplos de Valoración
P/E (Annual)
—
P/E (TTM)
—
P/FCF (Annual)
—
P/FCF (TTM)
—
EV/EBITDA
—
EV/Revenue
—
P/Sales
—
P/Book
1.8×
Rentabilidad (Último Anual)
Gross Margin
—
Operating Margin
—
Net Margin
—
FCF Margin
—
ROE
-146.4%
ROCE
-149.3%
ROA
-112.9%
Effective Tax Rate
0.0%
Métricas TTM
Revenue TTM
—
Gross Profit TTM
—
Operating Income TTM
−$7M
Net Income TTM
−$7M
FCF TTM
—
EPS TTM
-13.78
Quarters Used
4
TTM Period
2025-09-30 → 2026-06-30
Solidez del Balance
Net Debt
—
Net Debt / EBITDA
—
Debt / Equity
—
Current Ratio
3.85
Interest Coverage
—
Working Capital
$4M
Book Value / Share
3.05
Net Debt / Share
—
Crecimiento (YoY)
Revenue YoY
—
Net Income YoY
+46.6%
FCF YoY
+8.4%
EPS Diluted YoY
-23.7%
Retorno al Accionista
Dividend Yield
—
Payout Ratio
—
FCF / Share
-4.37
CapEx % Revenue
—
Rev / Employee
—
Empresas similares
Smart Money
vs Sector: Healthcare (1130 empresas)
MétricaAEMDMediana SectorΔ
Gross Margin—57.0%—
Operating Margin—-38.6%—
Net Margin—-33.6%—
FCF Margin—-13.9%—
ROE-146.4%-40.4%-106.0%
ROA-112.9%-32.0%-80.9%
Current Ratio3.852.84+1.01
Debt / Equity—0.28—
Scoring Fundamental
Capital Allocation
1/ 8Débil
✗FCF+Free cash flow positivo
✗FCFmMargen FCF > 10%
✓DilucSin dilución significativa (< 2%/año en 3 años)
✗Rev↑Revenue CAGR 3 años > 5%
✗ROCERetorno sobre capital empleado > 10%
✗DeudaDeuda neta/EBITDA < 3× (o posición de caja neta)
✗Mg↑Margen operativo ≥ hace 2-3 años (tolerancia -2pp)
✗Inv.R&D + Capex > 3% de revenue (reinversión en el negocio)